SeaStar Medical Holding Corporation has announced a Special Meeting of Stockholders to be held virtually on November 26, 2024. The meeting will address three key proposals: the ratification of previously issued shares in accordance with Nasdaq rules, an amendment to reduce the number of authorized shares of common stock, and a proposal to adjourn the meeting if necessary. The ratification relates to shares issued upon conversion of certain convertible notes and exercise of warrants, which may not have been fully covered by prior stockholder approval. The amendment proposes to reduce authorized shares from 500 million to 450 million, following a 25-for-1 reverse stock split. The adjournment proposal allows for rescheduling if there are insufficient votes for the other proposals. Stockholders as of October 24, 2024, are entitled to vote and are urged to do so promptly. The Board of Directors recommends voting FOR all proposals.

SeaStar Medical Holding Corporation has announced a Special Meeting of Stockholders to be held virtually on November 26, 2024. The meeting will address three key proposals: the ratification of previously issued shares in accordance with Nasdaq rules, an amendment to reduce the number of authorized shares of common stock, and a proposal to adjourn the meeting if necessary. The ratification relates to shares issued upon conversion of certain convertible notes and exercise of warrants, which may not have been fully covered by prior stockholder approval. The amendment proposes to reduce authorized shares from 500 million to 450 million, following a 25-for-1 reverse stock split. The adjournment proposal allows for rescheduling if there are insufficient votes for the other proposals. Stockholders as of October 24, 2024, are entitled to vote and are urged to do so promptly. The Board of Directors recommends voting FOR all proposals.